SCHEMBL9951612

SCHEMBL9951612

CC(C)(C)C(O[SiH](c1ccccc1)c1ccccc1)C1CC1(CO)c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 1/20 0.36
MAOB P27338 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2117867 1.00 OPRK1 (0.36) OPRK1MAOB
SCHEMBL2118625 0.89 KDM1A (0.33) OPRK1
SCHEMBL9950742 0.89 MAOB (0.31) MAOB
SCHEMBL15162446 0.88
SCHEMBL9951864 0.81 MAOB (0.32) MAOB
SCHEMBL2117762 0.79
SCHEMBL9950857 0.79
SCHEMBL9951233 0.78 HSD11B1 (0.34)
SCHEMBL9950173 0.78 HCRTR2 (0.54)
SCHEMBL2119023 0.77 HCRTR1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120165339-A1 CYCLOPROPANE DERIVATIVES EISAI R&D MANAGEMENT CO., LTD. (JP) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165339-A1 CYCLOPROPANE DERIVATIVES HCRTR2, HCRTR1, CNR1 OPRK1 61/4885MAOB 546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.